Austere Pharma facility at UK, started its commercial production from 2010. The plant is in accordance with the guidelines of various international regulatory bodies like US-FDA, TGA, MHRA, MCC, WHO, ANVISA etc, which is the true testimony of Megasys’s commitment towards quality and safety. Such standards helped Austere to attain strong footholds in the global market.
Infrastructure
The current pharmaceutical supply chain scenario in India is complex. In India, large number of medicines are required to be transported to the distant areas through various modes of transport. Austere has developed a robust and optimized model by integrating road, air, sea and rail transport in the most effective way. The strategic location of the plant is the backbone of supply chain integration.